Log in to search using one of your social media accounts:

 

Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly

The burden of nonalcoholic fatty liver disease (NAFLD) is increasing greatly, and the need for liver transplants is likely to outstrip the supply of donors, researchers report.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Related Links:

Nonalcoholic fatty liver disease (NAFLD) has become a common worldwide condition, the prevalence of which continues to increase with the worldwide surge in the incidence of obesity and diabetes. In the United States alone, NAFLD affects between 60 and 100 million people, including 10% of American children. The spectrum of disease ranges from simple, nonclinically significant hepatic steatosis to steatohepatitis (NASH) to cirrhosis, hepatocellular carcinoma, and decompensated liver disease. In 2016, NAFLD was reported to surpass hepatitis C as the leading indication for liver transplantation among adults under the age of 50...
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Tags: Preface Source Type: research
Conclusions: With continued high rates of adult obesity and DM, and an aging population, NAFLDā€related liver disease and mortality will increase in the US. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. This article is protected by copyright. All rights reserved.
Source: Hepatology - Category: Internal Medicine Authors: Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
Abstract Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third cause of cancer-related death in the Western Countries. The well-established causes of HCC are chronic liver infections such as hepatitis B virus or chronic hepatitis C virus, nonalcoholic fatty liver disease, consumption of aflatoxins and tobacco smocking. Clinical presentation varies widely; patients can be asymptomatic while symptomatology extends from right upper abdominal quadrant paint and weight loss to obstructive jaundice and lethargy. Imaging is the first key and one of the most important aspects at all st...
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Tags: World J Gastroenterol Source Type: research
Authors: Agustin S, Graupera I, Caballeria J, en nombre del grupo de trabajo sobre «Hígado graso no alcohólico» de la Societat Catalana de Digestologia Abstract Non-alcoholic fatty liver disease (NAFLD) consists of an excessive depositing of fat in the liver, which can end up by causing inflammation, fibrosis and also cirrhosis with the corresponding complications including liver cancer. NAFLD has become the most common liver disease worldwide. The incidence has increased in parallel with the obesity, diabetes and metabolic syndrome epidemic, thus resulting in becoming one of the main indi...
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
Authors: Benedict M, Zhang X Abstract Non-alcoholic fatty liver disease (NAFLD) encompasses the simple steatosis to more progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases hepatocellular carcinoma. NAFLD is a growing epidemic, not only in the United States, but worldwide in part due to obesity and insulin resistance leading to liver accumulation of triglycerides and free fatty acids. Numerous risk factors for the development of NAFLD have been espoused with most having some form of metabolic derangement or insulin resistance at the core of its pathophysiology. NAFLD patients are...
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research
Authors: Cholankeril G, Patel R, Khurana S, Satapathy SK Abstract With the prevalence of hepatitis C virus expected to decline, the proportion of hepatocellular carcinoma (HCC) related to non-alcoholic steatohepatitis (NASH) is anticipated to increase exponentially due to the growing epidemic of obesity and diabetes. The annual incidence rate of developing HCC in patients with NASH-related cirrhosis is not clearly understood with rates ranging from 2.6%-12.8%. While multiple new mechanisms have been implicated in the development of HCC in NASH; further prospective long-term studies are needed to validate these find...
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research
Hepatocellular carcinoma (HCC) is one of the most common human malignancies and the third leading cause of cancer death worldwide [1]. A retrospective cohort study of indications for adult liver transplantation from 2002 to 2012 revealed a nearly 4-fold increase in patients undergoing liver transplantation for HCC secondary to non-alcoholic steatohepatitis (NASH) compared to only a 2.5-fold increase for HCC secondary to HCV during the study period [2]. With the control of viral hepatitis and the escalating obesity epidemic, nonalcoholic fatty liver disease (NAFLD) associated HCC is occupying a greater proportion of HCC inc...
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
This article is protected by copyright. All rights reserved.
Source: Hepatology - Category: Internal Medicine Authors: Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
The progressively increasing rates of obesity have led to a worldwide epidemic of nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome. It is currently the most common cause of liver disease worldwide and projected to be the leading indication for liver transplantation in the United States by 2020. NAFLD is associated with both liver-related and overall mortality. Undoubtedly, nutrition interventions are key in the treatment of NAFLD, to reverse the disease, and prevent disease progression, complications, and associated comorbidities, including cardiovascular disease and diabetes.
Source: Medical Clinics of North America - Category: Primary Care Authors: Source Type: research
Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing both in Europe and USA becoming one of the most frequent causes of chronic liver disease and predictably, one of the leading causes of liver transplantation (LT) both for end-stage liver disease and hepatocellular carcinoma. For most transplant teams around the world this will raise many challenges in terms on pre- and post-transplant management. Here we review the multifaceted impact of NAFLD on liver transplantation and will discuss: (1) NAFLD as frequent cause of cryptogenic cirrhosis, en...
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Review Source Type: research
More News: Epidemics | Epidemiology | Fatty Liver Disease (FLD) | Gastroenterology | Liver | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Transplant Surgery | Transplants | Urology & Nephrology